Tag: FDA enforcement

CHC_DTCadvertisement2

04/18/2022

Presentation of Risks in DTC Video, HCP Webpage Yields Enforcement Letter for Bausch Health

FDA-News (1)

02/28/2022

OPDP Warning Letter Cites CEO’s COVID Claims in Video for IND

socialmedia.news (1)

01/31/2022

OPDP Cites Lilly for Omission of Risk Info in Trulicity Instagram Post

CDER.News

12/13/2021

CDER Steps in to Issue Warning Letters for Vaping Products Deemed Drugs

FDA-News (1)

08/30/2021

OPDP Enforcement Letter to Eton Pharmaceuticals Cites Omission of Risk Info in Sponsored Links

07/26/2021

Amgen Gets OPDP Untitled Letter for Claims about Neulasta Onpro vs. PFS Delivery

FDA-News (1)

05/03/2021

FDA Clamps Down on Company for Failing to Submit Clinical Trial Data to ClinicalTrials.gov

CHC_general1

02/23/2021

OPDP Focuses on Misleading Opioid Claims Amid National Crisis

12/14/2020

Azurity Email Garners OPDP Enforcement Letter for False/Misleading Claims